ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $313,000 | +4.3% | 290,000 | 0.0% | 0.16% | -4.8% |
| Q3 2020 | $300,000 | -30.2% | 290,000 | -25.6% | 0.17% | -25.2% |
| Q2 2020 | $430,000 | -13.7% | 390,000 | -20.4% | 0.22% | -28.8% |
| Q1 2020 | $498,000 | -13.8% | 490,000 | -3.0% | 0.31% | +13.5% |
| Q4 2019 | $578,000 | -1.9% | 505,000 | -1.9% | 0.28% | -37.4% |
| Q3 2019 | $589,000 | -8.4% | 515,000 | +8.4% | 0.44% | -26.8% |
| Q2 2019 | $643,000 | +2.1% | 475,000 | +2.2% | 0.60% | +50.4% |
| Q1 2019 | $630,000 | +15.4% | 465,000 | -8.8% | 0.40% | -6.1% |
| Q4 2018 | $546,000 | +1.7% | 510,000 | 0.0% | 0.42% | +18.1% |
| Q3 2018 | $537,000 | -4.3% | 510,000 | -10.5% | 0.36% | +18.0% |
| Q2 2018 | $561,000 | +1.1% | 570,000 | +1.8% | 0.30% | -14.3% |
| Q1 2018 | $555,000 | – | 560,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 16,935,000 | $17,946,697,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $48,504,000 | 2.18% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $21,312,000 | 1.66% |
| LINDEN ADVISORS LP | 34,494,000 | $36,562,000 | 1.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 96,239,000 | $101,731,000 | 1.13% |
| MACKAY SHIELDS LLC | 24,155,000 | $25,567,000 | 0.95% |
| Verition Fund Management LLC | 10,200,000 | $10,799,000 | 0.87% |
| Jabre Capital Partners S.A. | 4,000,000 | $4,243,000 | 0.82% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 38,030,000 | $40,330,000 | 0.76% |
| AQR Arbitrage LLC | 44,600,000 | $47,220,000 | 0.51% |